GoodRx Holdings Inc (GDRX) Actualités

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that...

GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties

50 Million Americans Face Critical Gaps in Care as Demand for Endocrinologists Surges Living in an Endocrinology Desert Increases Mortality Risk...

Form 8-K - Current report

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

Wendy Barnes, Current CEO of RxBenefits, Brings Extensive Healthcare Management Experience to the Company...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

In 2024, fills for Wegovy and Zepbound increased by over 100% and 300%, respectively GoodRx (Nasdaq: GDRX), the leading prescription savings...

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm PR Newswire NEW YORK, Nov. 13...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

GoodRx Reports Third Quarter 2024 Results

GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has...

Form 8-K - Current report

GoodRx to Participate in Upcoming Investor Conferences

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that...